دورية أكاديمية
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
| العنوان: | Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
|---|---|
| المؤلفون: | Alexander, J, Selinger, CP, Powell, N |
| المساهمون: | Pfizer Limited |
| المصدر: | 988 ; 987 |
| بيانات النشر: | Elsevier |
| سنة النشر: | 2021 |
| المجموعة: | Imperial College London: Spiral |
| مصطلحات موضوعية: | Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, POLYSACCHARIDE, Adolescent, Adult, Aged, 80 and over, COVID-19, COVID-19 Vaccines, Child, Humans, Immunization Schedule, Immunization, Secondary, Immunocompromised Host, Immunosuppressive Agents, Inflammatory Bowel Diseases, Middle Aged, Practice Guidelines as Topic, United Kingdom, Young Adult, British Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | unknown |
| تدمد: | 2468-1253 |
| العلاقة: | The Lancet Gastroenterology & Hepatology; http://hdl.handle.net/10044/1/92004Test |
| DOI: | 10.1016/S2468-1253(21)00374-5 |
| الإتاحة: | https://doi.org/10.1016/S2468-1253Test(21)00374-5 http://hdl.handle.net/10044/1/92004Test |
| حقوق: | © 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.B9E42895 |
| قاعدة البيانات: | BASE |
| تدمد: | 24681253 |
|---|---|
| DOI: | 10.1016/S2468-1253(21)00374-5 |